Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Iressa

This product is the most expensive of its product family


Contraindicated
Reproductive toxicity in animals

Contraindicated
Iressa :
Type Medicine Authorised
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory AstraZeneca
Responsible Party AstraZeneca UK Ltd
Origin UK
Manufacturer NIPRO Pharma Corporation, Kagamiishi Plant
Origin Japan
ATC L01XE02

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 01/10/2009

Iressa  MoH 6238 :
Form Tablet, Film-Coated
Package Size Box of 30
Strength 250mg
Storage Condition <30°C Away from moisture
Public Price 2326878 L.L.
Stratum E2
NSSF
Quarantine
Reg. Number 218930/10
Submission date 01/01/2010
Registration Year 2011





Price Comparison

Country: Italy
Package Size: 30
Public Price: 3614.98 EUR ( 350,204,802.48 LBP )
Pack size unit used: 30
Cost/Unit: 120,4993 EUR ( 11,625,120.00 LBP )
Exfactory Price: 2190.37 EUR
Pricing Date: 17/12/2019
Type: Medicine Authorised

Country: Germany
Package Size: 30
Public Price: 3371.51 EUR ( 326,618,402.76 LBP )
Pack size unit used: 30
Cost/Unit: 112,3837 EUR ( 10,850,112.00 LBP )
Pricing Date: 24/10/2020
Type: Medicine Authorised

Country: Switzerland
Package Size: 30
Public Price: 2588.7 CHF ( 267,723,354.00 LBP )
Pack size unit used: 30
Cost/Unit: 86,29 CHF ( 8,894,120.00 LBP )
Exfactory Price: 2304.28 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: The Netherlands
Package Size: 30
Public Price: 2589.22 EUR ( 250,833,276.72 LBP )
Pack size unit used: 30
Cost/Unit: 86,3073 EUR ( 8,331,336.00 LBP )
Pharmacy Price: 2582.22 EUR ( 250155144.72 LBP )
Reference: Zorginstituut Nederland
Pricing Date: 15/06/2019
Type: Medicine Authorised

Country: Qatar
Package Size: 30
Public Price: 10074 QAR ( 247,397,292.00 LBP )
Pack size unit used: 30
Cost/Unit: 335,8 QAR ( 8,226,930.00 LBP )
Pharmacy Price: 8274.9446 QAR ( 203216089.4868 LBP )
Pricing Date: 28/01/2021
Type: Medicine Authorised

Country: UK
Package Size: 30
Public Price: 2167.71 GBP ( 246,358,073.79 LBP )
Pack size unit used: 30
Cost/Unit: 72,257 GBP ( 8,182,728.00 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Denmark
Package Size: 30
Public Price: 17834.6 DKK ( 231,421,769.60 LBP )
Pack size unit used: 30
Cost/Unit: 594,4867 DKK ( 7,707,744.00 LBP )
Pharmacy Price: 13254.85 DKK ( 171994933.6 LBP )
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Authorised

Country: Iceland
Package Size: 30
Public Price: 353850 ISK ( 228,233,250.00 LBP )
Pack size unit used: 30
Cost/Unit: 11795 ISK ( 7,607,775.00 LBP )
Pharmacy Price: 279402 ISK ( 180214290 LBP )
Reference: Icelandic Medicines Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Abu Dhabi
Package Size: 30
Public Price: 9413.5 AED ( 227,439,573.50 LBP )
Pack size unit used: 30
Cost/Unit: 313,7833 AED ( 7,562,393.00 LBP )
Pharmacy Price: 8018.95 AED ( 193745850.95 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: UAE
Package Size: 30's (10's Blister x 3)
Public Price: 9413.5 AED ( 227,439,573.50 LBP )
Pack size unit used: 30
Cost/Unit: 313,7833 AED ( 7,562,393.00 LBP )
Pharmacy Price: 8018.95 AED ( 193745850.95 LBP )
Pricing Date: 21/08/2019
Type: Medicine Authorised

Country: Belgium
Package Size: 30
Public Price: 2331 EUR ( 225,817,956.00 LBP )
Pack size unit used: 30
Cost/Unit: 77,7 EUR ( 7,459,452.00 LBP )
Reference: cbip
Pricing Date: 02/12/2020
Type: Medicine Authorised

Country: Oman
Package Size: 30
Public Price: 970.64 OMR ( 223,959,649.76 LBP )
Pack size unit used: 30
Cost/Unit: 32,3547 OMR ( 7,383,488.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Finland
Package Size: 30
Public Price: 2299.61 EUR ( 222,777,018.36 LBP )
Pack size unit used: 30
Cost/Unit: 76,6537 EUR ( 7,362,576.00 LBP )
Reference: Kela
Pricing Date: 22/04/2021
Type: Medicine Authorised

Country: Kuweit
Package Size: Boîte de 30
Public Price: 756.34 KWD ( 222,047,053.54 LBP )
Pack size unit used: 30
Cost/Unit: 25,2113 KWD ( 7,339,525.00 LBP )
Pharmacy Price: 638.98 KWD ( 187592387.38 LBP )
Pricing Date: 07/02/2021
Type: Medicine Authorised

Country: Czech Republic
Package Size: 30
Public Price: 57486.92 CZK ( 219,542,547.48 LBP )
Pack size unit used: 30
Cost/Unit: 1916,2307 CZK ( 7,317,204.00 LBP )
Reference: SUKL
Pricing Date: 28/02/2020
Type: Medicine Authorised

Country: Ireland
Package Size: 30
Public Price: 2274.36 EUR ( 220,330,899.36 LBP )
Pack size unit used: 30
Cost/Unit: 75,812 EUR ( 7,265,700.00 LBP )
Pricing Date: 08/10/2020
Type: Medicine Authorised

Country: Spain
Package Size: 30
Public Price: 2185.34 EUR ( 211,706,997.84 LBP )
Pack size unit used: 30
Cost/Unit: 72,8447 EUR ( 6,975,072.00 LBP )
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Authorised

Country: Bahrain
Package Size: 30
Public Price: 819.38 BHD ( 194,794,484.92 LBP )
Pack size unit used: 30
Cost/Unit: 27,3127 BHD ( 6,418,818.00 LBP )
Reference: nhra
Pricing Date: 09/02/2021
Type: Medicine Authorised

Country: Cyprus
Package Size: 30 TABS
Public Price: 1979.02 EUR ( 191,719,541.52 LBP )
Pack size unit used: 30
Cost/Unit: 65,9673 EUR ( 6,296,940.00 LBP )
Reference: Cyprus Minister of Health
Pricing Date: 24/03/2021
Type: Medicine Authorised

Country: France
Package Size: 30
Public Price: 1971.63 EUR ( 191,003,627.88 LBP )
Pack size unit used: 30
Cost/Unit: 65,721 EUR ( 6,296,940.00 LBP )
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: KSA
Package Size: 30
Public Price: 7889.45 SAR ( 186,506,598.00 LBP )
Pack size unit used: 30
Cost/Unit: 262,9817 SAR ( 6,193,680.00 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: Sweden
Package Size: 30
Public Price: 20899.65 SEK ( 175,724,257.20 LBP )
Pack size unit used: 30
Cost/Unit: 696,655 SEK ( 5,851,968.00 LBP )
Pharmacy Price: 20433.24 SEK ( 171802681.92 LBP )
Pricing Date: 27/12/2019
Type: Medicine Non Marketed

Country: Greece
Package Size: 30
Public Price: 1777.2 EUR ( 172,168,027.20 LBP )
Pack size unit used: 30
Cost/Unit: 59,24 EUR ( 5,715,684.00 LBP )
Exfactory Price: 1592.12 EUR
Pharmacy Price: 1616 EUR ( 156551616 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/02/2021
Type: Medicine Authorised

Country: Norway
Package Size: 30
Public Price: 20640.8 NOK ( 167,273,043.20 LBP )
Pack size unit used: 30
Cost/Unit: 688,0267 NOK ( 5,575,552.00 LBP )
Pharmacy Price: 16160.44 NOK ( 130964205.76 LBP )
Reference: Norwegian Medicine Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Jordan
Package Size: 30
Public Price: 1192.48 JOD ( 149,323,538.08 LBP )
Pack size unit used: 30
Cost/Unit: 39,7493 JOD ( 4,883,619.00 LBP )
Pharmacy Price: 1146.62 JOD ( 143580903.02 LBP )
Reference: JFDA
Pricing Date: 02/01/2021
Type: Medicine Authorised

Country: Egypt
Package Size: 30
Public Price: 10600 EGP ( 19,345,000.00 LBP )
Pack size unit used: 30
Cost/Unit: 353,3333 EGP ( 644,225.00 LBP )
Pricing Date: 20/11/2019
Type: Medicine Authorised

Country: Turkey
Package Size: 30
Public Price: 4901.06 TRY ( 13,134,840.80 LBP )
Pack size unit used: 30
Cost/Unit: 163,3687 TRY ( 436,840.00 LBP )
Pricing Date: 28/10/2020
Type: Medicine Authorised

Country: Lebanon
Form: Tablet, Film-Coated
Package Size: Box of 30
Public Price: 2326878 LBP ( 2,326,878.00 LBP )
Pack size unit used: 30
Cost/Unit: 77562,6 LBP ( 77,562.00 LBP )
Pricing Date: 13/06/2024

Country: New Zealand
Package Size: 30 tab
Exfactory Price: 1700 NZD
Reference: New Zealand Pharmaceutical Management Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Portugal
Package Size: 30
Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
Pricing Date: 22/04/2019
Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 120,4993 EUR ( 11,625,120.00 LBP )
Cost/Day: 120,5 EUR ( 11,625,120.00 LBP )
Cost/Month: 3615 EUR ( 350,206,740.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 112,3837 EUR ( 10,850,112.00 LBP )
Cost/Day: 112,38 EUR ( 10,850,112.00 LBP )
Cost/Month: 3371,4 EUR ( 326,568,996.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 86,29 CHF ( 8,894,120.00 LBP )
Cost/Day: 86,29 CHF ( 8,894,120.00 LBP )
Cost/Month: 2588,7 CHF ( 267,650,960.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 86,3073 EUR ( 8,331,336.00 LBP )
Cost/Day: 86,31 EUR ( 8,331,336.00 LBP )
Cost/Month: 2589,3 EUR ( 250,811,964.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 335,8 QAR ( 8,226,930.00 LBP )
Cost/Day: 335,8 QAR ( 8,226,930.00 LBP )
Cost/Month: 10074 QAR ( 247,397,292.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 72,257 GBP ( 8,182,728.00 LBP )
Cost/Day: 72,26 GBP ( 8,182,728.00 LBP )
Cost/Month: 2167,8 GBP ( 246,277,383.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 594,4867 DKK ( 7,707,744.00 LBP )
Cost/Day: 594,49 DKK ( 7,707,744.00 LBP )
Cost/Month: 17834,7 DKK ( 231,413,984.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 11795 ISK ( 7,607,775.00 LBP )
Cost/Day: 11795 ISK ( 7,607,775.00 LBP )
Cost/Month: 353850 ISK ( 228,233,250.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 313,7833 AED ( 7,562,393.00 LBP )
Cost/Day: 313,78 AED ( 7,562,393.00 LBP )
Cost/Month: 9413,4 AED ( 227,427,493.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 313,7833 AED ( 7,562,393.00 LBP )
Cost/Day: 313,78 AED ( 7,562,393.00 LBP )
Cost/Month: 9413,4 AED ( 227,427,493.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 77,7 EUR ( 7,459,452.00 LBP )
Cost/Day: 77,7 EUR ( 7,459,452.00 LBP )
Cost/Month: 2331 EUR ( 225,817,956.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 32,3547 OMR ( 7,383,488.00 LBP )
Cost/Day: 32,35 OMR ( 7,383,488.00 LBP )
Cost/Month: 970,5 OMR ( 223,811,980.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 76,6537 EUR ( 7,362,576.00 LBP )
Cost/Day: 76,65 EUR ( 7,362,576.00 LBP )
Cost/Month: 2299,5 EUR ( 222,717,924.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 25,2113 KWD ( 7,339,525.00 LBP )
Cost/Day: 25,21 KWD ( 7,339,525.00 LBP )
Cost/Month: 756,3 KWD ( 221,947,236.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 1916,2307 CZK ( 7,317,204.00 LBP )
Cost/Day: 1916,23 CZK ( 7,317,204.00 LBP )
Cost/Month: 57486,9 CZK ( 219,539,034.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 75,812 EUR ( 7,265,700.00 LBP )
Cost/Day: 75,81 EUR ( 7,265,700.00 LBP )
Cost/Month: 2274,3 EUR ( 220,296,024.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 72,8447 EUR ( 6,975,072.00 LBP )
Cost/Day: 72,84 EUR ( 6,975,072.00 LBP )
Cost/Month: 2185,2 EUR ( 211,674,060.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 27,3127 BHD ( 6,418,818.00 LBP )
Cost/Day: 27,31 BHD ( 6,418,818.00 LBP )
Cost/Month: 819,3 BHD ( 194,704,146.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 65,721 EUR ( 6,296,940.00 LBP )
Cost/Day: 65,72 EUR ( 6,296,940.00 LBP )
Cost/Month: 1971,6 EUR ( 190,942,596.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 65,9673 EUR ( 6,296,940.00 LBP )
Cost/Day: 65,97 EUR ( 6,296,940.00 LBP )
Cost/Month: 1979,1 EUR ( 191,717,604.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 262,9817 SAR ( 6,193,680.00 LBP )
Cost/Day: 262,98 SAR ( 6,193,680.00 LBP )
Cost/Month: 7889,4 SAR ( 186,495,960.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 696,655 SEK ( 5,851,968.00 LBP )
Cost/Day: 696,66 SEK ( 5,851,968.00 LBP )
Cost/Month: 20899,8 SEK ( 175,718,792.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 59,24 EUR ( 5,715,684.00 LBP )
Cost/Day: 59,24 EUR ( 5,715,684.00 LBP )
Cost/Month: 1777,2 EUR ( 172,148,652.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 688,0267 NOK ( 5,575,552.00 LBP )
Cost/Day: 688,03 NOK ( 5,575,552.00 LBP )
Cost/Month: 20640,9 NOK ( 167,266,560.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 39,7493 JOD ( 4,883,619.00 LBP )
Cost/Day: 39,75 JOD ( 4,883,619.00 LBP )
Cost/Month: 1192,5 JOD ( 149,263,432.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 353,3333 EGP ( 644,225.00 LBP )
Cost/Day: 353,33 EGP ( 644,225.00 LBP )
Cost/Month: 10599,9 EGP ( 19,343,175.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 163,3687 TRY ( 436,840.00 LBP )
Cost/Day: 163,37 TRY ( 436,840.00 LBP )
Cost/Month: 4901,1 TRY ( 13,134,680.00 LBP )
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK : (Adults)
Cost/Unit: 77562,6 LBP ( 77,562.00 LBP )
Cost/Day: 77562,6 LBP ( 77,562.00 LBP )
Cost/Month: 2326878 LBP ( 2,326,878.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info